We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2.
- Authors
Ye Fan; Xia Gu; Jing Zhang; Sinn, Katharina; Klepetko, Walter; Na Wu; Foris, Vasile; Solymosi, Philip; Kwapiszewska, Grazyna; Kuebler, Wolfgang M.; Fan, Ye; Gu, Xia; Zhang, Jing; Wu, Na
- Abstract
Rationale: The bHLH (basic helix-loop-helix) transcription factor TWIST1 (Twist-related protein 1) controls cell proliferation and differentiation in tissue development and disease processes. Recently, endothelial TWIST1 has been linked to pulmonary hypertension (PH) and endothelial-to-mesenchymal transition, yet the role of TWIST1 in smooth muscle cells (SMCs) remains so far unclear.Objectives: To define the role of TWIST1 in SMCs in the pathogenesis of PH.Methods: SMC-specific TWIST1-deficient mice, SMC-specific TWIST1 silencing in rats, mass spectrometry, immunoprecipitation, and chromatin immunoprecipitation were used to delineate the role of SMC TWIST1 in PH.Measurements and Main Results: In pulmonary vessels from patients with PH and rodent PH models, TWIST1 expression was markedly increased and predominantly localized to SMCs. SMC-specific TWIST1 deficiency or silencing attenuated the development of PH and distal vessel muscularization in chronically hypoxic mice and in monocrotaline-treated rats. In vitro, TWIST1 inhibition or silencing prevented pulmonary artery SMC proliferation and migration. Mechanistically, the observed effects were mediated, at least in part, by TWIST1-dependent degradation of GATA-6 (GATA-binding protein 6). BMPR2 (bone morphogenetic protein receptor-2) was identified as a novel downstream target of GATA-6, which directly binds to its promoter. Inhibition of TWIST1 promoted the recruitment of GATA-6 to the BMPR2 promoter and restored BMPR2 functional expression.Conclusions: Our findings identify a key role for SMC TWIST1 in the pathogenesis of lung vascular remodeling and in PH that is partially mediated via reduced GATA-6-dependent BMPR2 expression. Inhibition of SMC TWIST1 may constitute a new therapeutic strategy for the treatment of PH.
- Subjects
SMOOTH muscle; CELL proliferation; PULMONARY hypertension; CELL differentiation; IMMUNOPRECIPITATION; PROTEINS; BIOLOGICAL models; RESEARCH; CELL culture; ANIMAL experimentation; RESEARCH methodology; CELL receptors; CELL physiology; EVALUATION research; MEDICAL cooperation; RATS; COMPARATIVE studies
- Publication
American Journal of Respiratory & Critical Care Medicine, 2020, Vol 202, Issue 9, p1283
- ISSN
1073-449X
- Publication type
journal article
- DOI
10.1164/rccm.201909-1884OC